AG
TAK icon

AmeriFlex Group’s Takeda Pharmaceutical TAK Stock Holding History

AmeriFlex Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7K Buy
+106
New +$1.75K ﹤0.01% 1309
2025
Q3 		– Sell
-503
Closed -$7.58K – 1348
2025
Q2 		$7.58K Hold
503
– – ﹤0.01% 764
2025
Q1 		$7.48K Buy
+503
New +$7.05K ﹤0.01% 918

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

AmeriFlex Group's TAK Position: Q2 2026 in Review

AmeriFlex Group opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 106 shares worth $1.7K. The stake represents ﹤0.01% of the portfolio and ranks #1309 among its holdings. This is a return to the name: AmeriFlex Group previously reported a position in TAK as recently as Q2 2025.

AmeriFlex Group first reported a position in TAK in Q1 2025 and has held it in 3 quarters since. The position peaked at $7.58K in Q2 2025. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • AmeriFlex Group held 106 shares of Takeda Pharmaceutical worth $1.7K as of Q2 2026.
  • Takeda Pharmaceutical was a new AmeriFlex Group position in Q2 2026.
  • Takeda Pharmaceutical made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #1309 holding.
  • AmeriFlex Group first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 3 quarters since.
  • AmeriFlex Group's Takeda Pharmaceutical position peaked at $7.58K in Q2 2025.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.